Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

FG Financial Group, Inc. (FGFPP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
22.68-0.55 (-2.37%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Down

Gap Down

Previous Close23.23
Open23.08
Bid17.50 x 1400
Ask22.70 x 1200
Day's Range22.51 - 23.20
52 Week Range22.00 - 26.00
Volume3,006
Avg. Volume3,073
Market CapN/A
Beta (5Y Monthly)0.66
PE Ratio (TTM)N/A
EPS (TTM)-1.75
Earnings DateN/A
Forward Dividend & Yield2.00 (8.57%)
Ex-Dividend DateNov 30, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for FGFPP

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • FG Financial Group, Inc. - 8.0
    Daily – Vickers Top Buyers & Sellers for 09/16/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • Investopedia

    Top Biotech Stocks for Q1 2022

    The biotechnology industry includes companies that develop drugs and diagnostic technologies for the treatment of diseases and medical conditions. This means that investors may wait for years before knowing whether a drug under development will pay off. Many biotech companies have shifted their focus entirely or added COVID-19 vaccine and treatments to their product pipeline.

  • Business Wire

    FG Financial Group, Inc. SPAC Platform Investment Aldel Financial Has Completed Business Combination with Hagerty

    ST. PETERSBURG, Fla., December 06, 2021--FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (the "Company"), a reinsurance and investment management holding company focused on opportunistic collateralized and loss capped reinsurance, while allocating capital in partnership with Fundamental Global® to SPAC and SPAC sponsor-related businesses, today announced that its SPAC Platform partner, Aldel Financial ("Aldel") (NYSE: ADF) has completed their previously announced business combination with Hagerty,

  • GlobeNewswire

    Ballantyne Strong Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of Strong Global Entertainment, Inc.

    Charlotte, NC, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company” or “Ballantyne”), the parent of Strong Global Entertainment, Inc. (“Strong Global Entertainment”) announced today that the Company has confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of common shares of Strong Global Entertainment. The number of shares and price range f

Advertisement
Advertisement